Literature DB >> 22717366

Synergistic effects of hypoxia and extracellular matrix cues in cardiomyogenesis.

Renita E Horton1, Debra T Auguste.   

Abstract

Limited characterization of how the stem cell niche evolves has hindered our ability to mimic the physiological environment. In this paper, we hypothesized that hypoxia-induced extracellular matrix (ECM) cues may facilitate cardiomyogenesis. We evaluated the expression of four ECM proteins - fibronectin, collagen I, collagen IV, and laminin - over a period of 20 days in H1 and H9 human embryonic stem cell-derived embryoid bodies (EBs) under hypoxic (5% oxygen) and normoxic (21% oxygen) conditions. Hypoxic EBs exhibited increased collagen I, collagen IV and fibronectin expression relative to normoxic EBs between days 9-13, which coincided with increased expression of mesoderm genes. The effect of ECM cues was confirmed by plating day 9 EBs on collagen IV, gelatin, and fibronectin-rich substrates for 11 days. Hypoxia/gelatin cultures synergistically increased the cardiomyocyte yield by 1.7 and 5.5 fold relative to normoxia/gelatin and normoxia/collagen IV cultures, respectively. Current differentiation protocols may underestimate the contribution of hypoxia and ECM cues that evolve during EB maturation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22717366     DOI: 10.1016/j.biomaterials.2012.05.063

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Low oxygen tension enhances the generation of lung progenitor cells from mouse embryonic and induced pluripotent stem cells.

Authors:  Elena Garreta; Esther Melo; Daniel Navajas; Ramon Farré
Journal:  Physiol Rep       Date:  2014-07-16

2.  Combinatorial fibronectin and laminin signaling promote highly efficient cardiac differentiation of human embryonic stem cells.

Authors:  Silin Sa; Lian Wong; Kara E McCloskey
Journal:  Biores Open Access       Date:  2014-08-01

3.  Combining hypoxia and bioreactor hydrodynamics boosts induced pluripotent stem cell differentiation towards cardiomyocytes.

Authors:  Cláudia Correia; Margarida Serra; Nuno Espinha; Marcos Sousa; Catarina Brito; Karsten Burkert; Yunjie Zheng; Jürgen Hescheler; Manuel J T Carrondo; Tomo Sarić; Paula M Alves
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

4.  Mitochondrial pyruvate dehydrogenase phosphatase 1 regulates the early differentiation of cardiomyocytes from mouse embryonic stem cells.

Authors:  Hye Jin Heo; Hyoung Kyu Kim; Jae Boum Youm; Sung Woo Cho; In-Sung Song; Sun Young Lee; Tae Hee Ko; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Exp Mol Med       Date:  2016-08-19       Impact factor: 8.718

Review 5.  The march of pluripotent stem cells in cardiovascular regenerative medicine.

Authors:  Haissam Abou-Saleh; Fouad A Zouein; Ahmed El-Yazbi; Despina Sanoudou; Christophe Raynaud; Christopher Rao; Gianfranco Pintus; Hassan Dehaini; Ali H Eid
Journal:  Stem Cell Res Ther       Date:  2018-07-27       Impact factor: 6.832

6.  Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids.

Authors:  Monia Souidi; Yvonne Sleiman; Ivana Acimovic; Jan Pribyl; Azzouz Charrabi; Volker Baecker; Valerie Scheuermann; Martin Pesl; Sarka Jelinkova; Petr Skladal; Petr Dvorak; Alain Lacampagne; Vladimir Rotrekl; Albano C Meli
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

7.  Integrating Oxygen and 3D Cell Culture System: A Simple Tool to Elucidate the Cell Fate Decision of hiPSCs.

Authors:  Rubina Rahaman Khadim; Raja Kumar Vadivelu; Tia Utami; Fuad Gandhi Torizal; Masaki Nishikawa; Yasuyuki Sakai
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

8.  Establishment of Insulin-Producing Cells From Human Embryonic Stem Cells Underhypoxic Condition for Cell Based Therapy.

Authors:  Piyaporn Rattananinsruang; Chavaboon Dechsukhum; Wilairat Leeanansaksiri
Journal:  Front Cell Dev Biol       Date:  2018-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.